| 000 | 01000 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513115331.0 | ||
| 264 | 0 | _c19970430 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(05)62904-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLarkin, M | |
| 245 | 0 | 0 |
_aNew asthma drugs target inflammatory cascade. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cApr 1997 |
||
| 300 |
_a1004 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndoles |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aLeukotriene Antagonists |
| 650 | 0 | 4 | _aPhenylcarbamates |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aTosyl Compounds _xpharmacology |
| 773 | 0 |
_tLancet (London, England) _gvol. 349 _gno. 9057 _gp. 1004 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(05)62904-2 _zAvailable from publisher's website |
| 999 |
_c9114029 _d9114029 |
||